Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Harmony Biosciences Hldgs In (HRMY)

308 + Investors. Track Smart Money conviction in HRMY. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -8
Streak
1Q ▼
Buyers last Q
54%

Smart Money Signals — HRMY

Based on 309 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their HRMY positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (97% of max)

97% of all-time peak
309 hedge funds hold HRMY right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +18% more funds vs a year ago

fund count last 6Q
+48 new funds entered over the past year (+18% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

177 buying148 selling
Last quarter: 177 funds bought or added vs 148 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-15 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 41 → 47 → 59 → 44. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

52% of holders stayed for 2+ years

■ 52% conviction (2yr+) ■ 27% medium ■ 21% new
161 out of 309 hedge funds have held HRMY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +11%, value -24%

Value
-23%
Shares
+10%
Last quarter: funds added +11% more shares while total portfolio value only changed -24%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

41 → 41 → 47 → 59 → 44 new funds/Q
New funds entering each quarter: 41 → 47 → 59 → 44. A growing number of institutions are discovering HRMY each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 59% veterans vs 29% newcomers

■ 59% veterans ■ 12% 1-2yr ■ 29% new
Entry-cohort mix of 316 holders: 187 (59%) are 2+ year veterans, 38 entered 1–2 years ago, and 91 (29%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
50 of 307 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in HRMY. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — HRMY

In 2026 Q1, 177 hedge funds were net buyers of HRMY (44 opened a new position, 133 added to an existing one), while 148 reduced or exited (96 trimmed, 52 sold completely) — a 54% buyer ratio, indicating a slight buying edge. 45% of total institutional value in HRMY is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -8 funds (more exits than new entries). Total institutional holders: 309.

Hedge Fund Ownership: HRMY

How many hedge funds hold HRMY — quarterly history vs. share price
Quarterly hedge fund ownership of HRMY vs. share price

Market Analysis: HRMY

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: HRMY

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Harmony Biosciences Hldgs In (HRMY) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much HRMY has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
HRMY
nan%
XLV
+2.1%

HRMY outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
HRMY
nan%
XLV
+3.2%

Since the filing became public, HRMY outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

25 top-rated funds 0 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
1.5
/ 10
conviction
Hedge Fund Positioning: HRMY
308 + Investors

Track Smart Money conviction in HRMY. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 308 317 -2.84%
13F Shares 56M 50M 10.89%
Total Value $1.43B $1.87B -23.6%
New Positions 43 59 -16
Increased Positions 131 117 +14
Closed Positions 52 36 +16
Reduced Positions 95 109 -14
Total Calls 4 4 -
Total Puts 5 3 66.67%
PUT/CALL Ratio 1.25 0.75 Bearish

Statistics: HRMY

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

308 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in HRMY. Verified SEC 13F-HR filings.

QUARTER:
Top 25 HRMY holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 venBio Partners LLC 4.88% 489,194 $13.7M
2 Tieton Capital Management, LLC 2.92% 311,496 $8.7M
3 Valor Management LLC 1.81% 117,130 $3.3M
4 Sidoxia Capital Management, LLC 1.67% 69,238 $1.9M
5 Capital Management Corp /Va 1.52% 317,925 $8.9M
6 Aurora Investment Counsel 0.98% 62,783 $1.8M
7 Armistice Capital, LLC 0.81% 1,624,000 $45.5M
8 Quantedge Capital Pte Ltd 0.77% 50,500 $1.4M
9 Tetragon Partners GP Ltd 0.65% 119,340 $3.3M
10 Nan Fung Group Holdings Ltd 0.62% 27,049 $758K
11 Clark Estates Inc/Ny 0.55% 81,300 $2.3M
12 Illumine Investment Management, LLC 0.52% 24,277 $680K
13 Hussman Strategic Advisors, INC. 0.51% 84,000 $2.4M
14 Diadema Partners LP 0.44% 92,864 $2.6M
15 Chase Investment Counsel Corp 0.37% 50,000 $1.4M
16 Hedeker Wealth, LLC 0.36% 60,865 $1.7M
17 Mirabella Financial Services LLP 0.31% 115,934 $3.2M
18 PSP Research LLC 0.28% 14,283 $400K
19 Persistent Asset Partners Ltd 0.25% 23,548 $660K
20 City Center Advisors, LLC 0.22% 8,686 $243K
21 Yelin Lapidot Holdings Management Ltd. 0.21% 35,887 $1.0M
22 Zuckerman Investment Group, LLC 0.21% 78,255 $2.2M
23 Virtus Advisers, LLC 0.20% 15,399 $431K
24 EntryPoint Capital, LLC 0.20% 24,264 $680K
25 Denali Advisors LLC 0.19% 59,900 $1.7M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Harmony Biosciences Hldgs In (HRMY)

What does the Smart Money Trend signal show for HRMY?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their HRMY positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for HRMY?

Slight buying edge — 54% buying: Last quarter: 177 funds bought or added vs 148 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for HRMY holders?

Elite ownership — 45% AUM from top-100 funds: 50 of 307 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in HRMY. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held HRMY?

52% of holders stayed for 2+ years: 161 out of 309 hedge funds have held HRMY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Harmony Biosciences Hldgs In (HRMY) following the 2026 Q1 hedge fund 13F filings?

As of today, HRMY has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), HRMY has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →